Issue: May 2019
May 21, 2019
3 min read
Save

WHO says Ebola outbreak still not an international health emergency

Issue: May 2019
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

For the second time, an emergency committee convened by WHO voted against declaring the Ebola virus outbreak in the Democratic Republic of the Congo, or DRC, an international public health emergency.

Perspective from Ronald Klain

Committee chairman Robert Steffen, MD, said members voted almost unanimously not to declare a public health emergency of international concern (PHEIC) despite worry about the duration of the outbreak, which began last summer, and a recent spike in the number of cases.

As he did in October when the committee also voted against declaring a PHEIC, Steffen indicated that the No. 1 reason for not doing so is that the outbreak has not spread beyond the DRC.

Tedros Adhanom Ghebreyesus, PhD, MSc
Tedros Adhanom Ghebreyesus

“If it stays within a country, by definition it’s not of international concern because it has not spread,” Steffen said.

WHO Director-General Tedros Adhanom Ghebreyesus, PhD, MSc, accepted the decision, but warned that the outbreak response remained underfunded by more than $100 million and asked that the international community step up its commitments.

“Stopping this outbreak is our collective responsibility,” he said.

Tedros has said that ongoing violence being perpetrated by armed militia groups threatens to reverse any gains that have been made in the outbreak. The number of confirmed and probable cases rose steadily during the first months of the year, climbing past 1,200 in mid-April, making it the second-largest Ebola outbreak on record after the West African epidemic. More than 800 people have died.

The violence has included attacks on Ebola treatment facilities, including one in March at a facility that was visited just hours later by Tedros and CDC Director Robert Redfield, MD.

Fearing cross-border spread, other countries have begun vaccinating health care and front-line workers with Merck’s experimental V920 vaccine — first Uganda, then South Sudan and Rwanda.

In the DRC, more than 100,000 people have received the vaccine. For the first time, WHO released data on the vaccine’s effectiveness, showing that it has been protective in 97.5% of the people who have received it.

Ebola outbreak expert Mike Ryan, MD, MPH, who heads WHO’s health emergency program, said the vaccine “is demonstrating remarkable efficacy against infection.”

The vaccine is being administered on a voluntary basis to contacts — and contacts of contacts — of confirmed Ebola patients as part of a ring trial. Around 10% of contacts have not accepted vaccination, which also has hindered control efforts, Ryan said. – by Gerard Gallagher and Caitlyn Stulpin

Disclosures: Ryan, Steffen and Tedros report no relevant financial disclosures.